Ground Swell Capital »

Pharmacyte Biotech shares owned by Ground Swell Capital

Quarter-by-quarter ownership of Pharmacyte Biotech (PMCB) shares owned by Ground Swell Capital from 13F filings

Historical chart of Ground Swell Capital investment in Pharmacyte Biotech

Tip: Access up to 7 years of quarterly data

All positions including Pharmacyte Biotech held by Ground Swell Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharmacyte Biotech by Ground Swell Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.7k 12k 0.67

More positions owned by Ground Swell Capital

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vaneck Etf Trust Pharmaceutcl Etf (PPH)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Ishares Semicdtr (SOXX)
Duolingo Cl A Com (DUOL)
State Str Spdr Dow Jones Ind Ut Ser 1 (DIA)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Evergy (EVRG)
Charter Communications Cl A (CHTR)
State Str Spdr S&p Midcap 40 Utser1 S&pdcrp (MDY)
Meta Platforms Cl A (META)
Intuitive Surgical Com New (ISRG)
Sandisk Corp (SNDK)

View all positions for Ground Swell Capital

Top funds holding Pharmacyte Biotech

Citadel Advisors
Hrt Financial
Geode Capital Management
Sabby Management
Renaissance Technologies
Vanguard Group
Northern Trust
Schonfeld Strategic Advisors
Simplex Trading
Two Sigma Securities
XTX Topco
Equitec Proprietary Markets
Ground Swell Capital
Jane Street
Commonwealth Equity Services

View all funds holding Pharmacyte Biotech